OIG Finds Significant Rise In Part D Spending On Compounded Drugs

Medicare Part D spending on compounded drugs grew from $70.2 million in 2006 to $508.7 million in 2015, and topical drugs accounted for an outsized portion of that growth, which raises suspicions of fraud, the HHS Office of Inspector General reports. Last year alone, Part D spending on compounded drugs rose $182 million. "The extremely high rate of growth raises questions as to whether all of the drugs were medically necessary or even dispensed to the beneficiary,” the June OIG...